A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia
| Autor: | Macek, Thomas A., McCue, Maggie, Dong, Xinxin, Hanson, Elizabeth, Goldsmith, Paul, Affinito, John, Mahableshwarkar, Atul R. |
|---|---|
| Zdroj: | In Schizophrenia Research February 2019 204:289-294 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect